🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchBimagrumab + semaglutide — myostatin inhibitor combo for body recomp Page 5

Bimagrumab + semaglutide — myostatin inhibitor combo for body recomp

MikeFit_NJ Thu, May 14, 2026 at 9:31 AM 22 replies 751 viewsPage 5 of 5
LondonLisa
Member
912
3,456
Mar 2024
London, UK
May 17, 2026 at 2:30 AM#21

Following on from Dr.PathRoch — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

18 18SaraMom3, Dr.MetabolicMD, RetaRick_CA and 15 others
Reply Quote Save Share Report
MASHdoc_SA
Member
456
2,345
Aug 2024
San Antonio, TX
May 17, 2026 at 7:34 PM#22
SandraNC_45 said:
The useful move here is to separate what is established from what is widely repeated.

Careful with the causal language. Two things moving together in a period when five things changed is not a mechanism, and stating it as one makes the thread less useful to somebody reading it later.

17 17TrialTracker_MD, JennaRN, LabKate and 14 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
May 18, 2026 at 12:38 PM#23
SandraNC_45 said:
The useful move here is to separate what is established from what is widely repeated.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

16 16maya_sedona, stefan_berlin, Dr.EM_Chicago and 13 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
james_edin
Member
289
1,234
Sep 2024
Edinburgh, UK
May 19, 2026 at 5:42 AM#24
SandraNC_45 said:
The useful move here is to separate what is established from what is widely repeated.

Thank you for spelling out the reasoning rather than just the conclusion.

Last edited: May 19, 2026 at 7:42 AM
15 15oliver_london, tane_welly, Dr.PathRoch and 12 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
May 19, 2026 at 10:45 PM#25

From the other side of the consultation, briefly. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

Last edited: May 20, 2026 at 4:45 AM
14 14kevin_tulsa, Dr.PainCLE, mike_mealprep and 11 others
Reply Quote Save Share Report
1345

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register